PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-1.36%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-13.75%
Cost reduction while VET shows 7.50% growth. Joel Greenblatt would examine competitive advantage.
7.74%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
9.22%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-5.69%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
-110.99%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-5.76%
Operating expenses reduction while VET shows 2.81% growth. Joel Greenblatt would examine advantage.
-10.57%
Total costs reduction while VET shows 5.44% growth. Joel Greenblatt would examine advantage.
89.47%
Interest expense growth above 1.5x VET's 0.19%. Michael Burry would check for over-leverage.
-5.25%
D&A reduction while VET shows 12.50% growth. Joel Greenblatt would examine efficiency.
4.43%
EBITDA growth while VET declines. John Neff would investigate advantages.
5.86%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
20.56%
Operating income growth while VET declines. John Neff would investigate advantages.
22.22%
Operating margin growth while VET declines. John Neff would investigate advantages.
-117.77%
Other expenses reduction while VET shows 389.97% growth. Joel Greenblatt would examine advantage.
-90.64%
Both companies show declining income. Martin Whitman would check industry conditions.
-90.51%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-81.71%
Both companies reducing tax expense. Martin Whitman would check patterns.
-92.95%
Net income decline while VET shows 8.79% growth. Joel Greenblatt would examine position.
-92.85%
Net margin decline while VET shows 22.52% growth. Joel Greenblatt would examine position.
-64.64%
EPS decline while VET shows 10.00% growth. Joel Greenblatt would examine position.
-64.64%
Diluted EPS decline while VET shows 8.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.